Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds

NCT01429519 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Due to slow recruitment

Conditions

Chronic Wound

Interventions

DRUG: RPh201, botanical drug product

Sponsor

Regenera Pharma Ltd

Collaborators

[object Object]